Ztalmy — United Healthcare
seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder
Initial criteria
- Diagnosis of seizures associated with CDKL5 deficiency disorder OR continuation of prior therapy for a seizure disorder
Reauthorization criteria
- Documentation of positive clinical response to therapy
Approval duration
12 months